Back to Search Start Over

IGF2 increases de novo steroidogenesis in prostate cancer cells.

Authors :
Lubik AA
Gunter JH
Hollier BG
Ettinger S
Fazli L
Stylianou N
Hendy SC
Adomat HH
Gleave ME
Pollak M
Herington A
Nelson CC
Source :
Endocrine-related cancer [Endocr Relat Cancer] 2013 Mar 22; Vol. 20 (2), pp. 173-86. Date of Electronic Publication: 2013 Mar 22 (Print Publication: 2013).
Publication Year :
2013

Abstract

IGF2 is a mitogenic foetal growth factor commonly over-expressed in cancers, including prostate cancer (PC). We recently demonstrated that insulin can activate de novo steroidogenesis in PC cells, a major pathway for reactivation of androgen pathways and PC progression. IGF2 can activate the IGF1 receptor (IGF1R) or insulin receptor (INSR) or hybrids of these two receptors. We therefore hypothesized that IGF2 may contribute to PC progression via de novo steroidogenesis. IGF2 mRNA but not IGF2 receptor mRNA expression was increased in patient samples during progression to castrate-resistant PC as was immunoreactivity to INSR and IGF1R antibodies. Treatment of androgen receptor (AR)-positive PC cell lines LNCaP and 22RV1 with IGF2 for 48 h resulted in increased expression of steroidogenic enzyme mRNA and protein, including steroid acute regulatory protein (StAR), cytochrome p450 family member (CYP)17A1, aldo-keto reductase family member (AKR)1C3 and hydroxysteroid dehydrogenase (HSD)17B3. IGF2 treatment resulted in increased steady state steroid levels and increased de novo steroidogenesis resulting in AR activation as demonstrated by PSA mRNA induction. Inhibition of the IGF1R/INSR signalling axis attenuated the effects of IGF2 on steroid hormone synthesis. We present a potential mechanism for prostatic IGF2 contributing to PC progression by inducing steroidogenesis and that IGF2 signalling and related pathways present attractive targets for PC therapy.

Details

Language :
English
ISSN :
1479-6821
Volume :
20
Issue :
2
Database :
MEDLINE
Journal :
Endocrine-related cancer
Publication Type :
Academic Journal
Accession number :
23319492
Full Text :
https://doi.org/10.1530/ERC-12-0250